propagermanium has been researched along with Coronary Artery Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eto, Y; Kandabashi, T; Matsushima, K; Miyata, K; Morishige, K; Shimokawa, H; Takeshita, A | 1 |
1 other study(ies) available for propagermanium and Coronary Artery Disease
| Article | Year |
|---|---|
Propagermanium suppresses macrophage-mediated formation of coronary arteriosclerotic lesions in pigs in vivo.
Topics: Animals; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Germanium; Macrophages; Male; Organometallic Compounds; Propionates; Swine | 2003 |